Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $629.73 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $248.08 | 9 | $0 (2020) |
| Novo Nordisk Inc | $139.93 | 7 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $104.42 | 5 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $33.38 | 2 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.70 | 1 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $22.37 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $17.08 | 1 | $0 (2020) |
| PFIZER INC. | $15.80 | 1 | $0 (2020) |
| Kowa Pharmaceuticals America, Inc. | $14.47 | 1 | $0 (2021) |
| Amarin Pharma Inc. | $11.50 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $116.49 | 5 | Novo Nordisk Inc ($94.12) |
| 2022 | $22.70 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($22.70) |
| 2021 | $14.47 | 1 | Kowa Pharmaceuticals America, Inc. ($14.47) |
| 2020 | $420.75 | 19 | AstraZeneca Pharmaceuticals LP ($192.76) |
| 2019 | $55.32 | 3 | AstraZeneca Pharmaceuticals LP ($55.32) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Gastroenterology | ||||||
| 08/27/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Diabetes | ||||||
| 03/22/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Diabetes | ||||||
| 02/19/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Diabetes | ||||||
| 10/10/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: DIABETES | ||||||
| 09/16/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $14.47 | General |
| Category: Cardiovascular | ||||||
| 12/17/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/23/2020 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: VACCINES | ||||||
| 09/14/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Endocrinology | ||||||
| 09/11/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/26/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Diabetes | ||||||
| 08/21/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Endocrinology | ||||||
| 07/27/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Diabetes | ||||||
| 07/08/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/07/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Endocrinology | ||||||
| 06/30/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Respiratory | ||||||
| 06/25/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Endocrinology | ||||||
| 05/13/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/06/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Endocrinology | ||||||
| 04/28/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Diabetes | ||||||
| 04/27/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Cardiovascular | ||||||
| 04/24/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/11/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/29/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $112.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 24 | 38 | $12,997 | $2,844 |
| 2022 | 2 | 27 | 32 | $14,455 | $2,849 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 27 | $12,150 | $2,640 | 21.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 11 | 11 | $847.00 | $203.72 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 21 | $9,450 | $1,991 | 21.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $5,005 | $857.93 | 17.1% |
About Dr. Ronel Desrosiers, M.D
Dr. Ronel Desrosiers, M.D is a General Practice healthcare provider based in Lauderhill, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2014. The National Provider Identifier (NPI) number assigned to this provider is 1437551884.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronel Desrosiers, M.D has received a total of $629.73 in payments from pharmaceutical and medical device companies, with $116.49 received in 2024. These payments were reported across 29 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($629.73).
As a Medicare-enrolled provider, Desrosiers has provided services to 51 Medicare beneficiaries, totaling 70 services with total Medicare billing of $5,693. Data is available for 2 years (2022–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Location Lauderhill, FL
- Active Since 09/17/2014
- Last Updated 02/01/2022
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437551884
Products in Payments
- FARXIGA (Drug) $232.63
- SOLIQUA 100/33 (Biological) $104.42
- Rybelsus (Drug) $94.12
- Ozempic (Drug) $45.81
- XARELTO (Drug) $33.38
- JARDIANCE (Drug) $22.70
- XIFAXAN (Drug) $22.37
- JANUVIA (Drug) $17.08
- PREVNAR 13 (Biological) $15.80
- SYMBICORT (Drug) $15.45
- Livalo (Drug) $14.47
- Vascepa (Drug) $11.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Lauderhill
Dr. Anita Kianimanesh, D.m.d, D.M.D
General Practice — Payments: $3,648
Mrs. Rosario Tucci, Md, MD
General Practice — Payments: $1,768
Dr. Mohammad Sheikh
General Practice — Payments: $873.63
Dr. George Brockman, Dds, DDS
General Practice — Payments: $650.00
Dr. Americo Hajaz, Md, MD
General Practice — Payments: $403.81
Dr. Mitchell Klein, Dds, DDS
General Practice — Payments: $253.57